CMA accuses more drugmakers of collusion
Auden Mckenzie and its parent company face four separate allegations of collusion in the UK drug market from the Competition and Markets Authority.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.